loadpatents
name:-0.010795116424561
name:-0.0072751045227051
name:-0.00039792060852051
Fecher; Anja Patent Filings

Fecher; Anja

Patent Applications and Registrations

Patent applications and USPTO patent grants for Fecher; Anja.The latest application filed is for "tetrhydropyridoindole derivatives".

Company Profile
0.7.7
  • Fecher; Anja - Basel CH
  • Fecher; Anja - Allschwil CH
  • Fecher; Anja - Weil am Rhein DE
  • Fecher; Anja - Weil an Rhein DE
  • Fecher, Anja - Eisenbahnstr.16 DE
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
2,3,4,9-tetrahydro-1H-carbazole derivatives as CRTH2 receptor antagonists
Grant 8,039,474 - Fecher , et al. October 18, 2
2011-10-18
Indol-1-yl-acetic acid derivatives
Grant 7,897,788 - Fecher , et al. March 1, 2
2011-03-01
Tetrhydropyridoindole Derivatives
App 20100234396 - Fecher; Anja ;   et al.
2010-09-16
Guanidine derivatives and their use as neuropeptide FF receptor antagonists
Grant 7,727,979 - Caroff , et al. June 1, 2
2010-06-01
Tetrahydropyridoindole derivatives
Grant 7,714,132 - Fecher , et al. May 11, 2
2010-05-11
2,3,4,9- Tetrahydro-1h-carbazole Derivatives As Crth2 Receptor Antagonists
App 20090270414 - Fecher; Anja ;   et al.
2009-10-29
Guanidine derivatives
Grant 7,544,691 - Breu , et al. June 9, 2
2009-06-09
Indol-1-yl-acetic acid derivatives
App 20070208004 - Fecher; Anja ;   et al.
2007-09-06
Tetrahydropyridoindole derivatives
App 20070191416 - Fecher; Anja ;   et al.
2007-08-16
Guanidine derivatives
App 20070123510 - Breu; Volker ;   et al.
2007-05-31
Prodrugs for a selective cancer therapy
Grant 7,214,685 - Tietze , et al. May 8, 2
2007-05-08
Guanidine derivatives and their use as neuropeptide ff receptor antagonists
App 20060194788 - Caroff; Eva ;   et al.
2006-08-31
Novel prodrugs von 6-hydroxy-2,3-dihydro-1h-indoles, 5-hydroxy-1,2-dihydro-3h-pyrrolo[3,2-e]indoles and 5-hydroxy-1,2-dihydro-3h-benzo(e)indoles as well as of 6-hydroxy-1,2,3,4-tetrahydro-benzo[f]quinoline derivatives for use in selective cancer therapy
App 20040033962 - Tietze, Lutz F. ;   et al.
2004-02-19

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed